Form 4: Parul Bhandari Receives Stock Options in National Research Corp (NRC)

Sentiment:

SEC Form 4 Filing


Director Parul Bhandari was granted stock options for 34,917 shares of National Research Corp (NRC) at an exercise price of $13.09 on May 7, 2025, according to a Form 4 filing.

Summary

  • Parul Bhandari, a director of National Research Corp (NRC), received a grant of stock options on May 7, 2025.
  • The options are for 34,917 shares of common stock.
  • The exercise price of the options is $13.09 per share.
  • The options were granted under the Issuer's 2025 Omnibus Incentive Plan.
  • The options will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions.
  • The options expire on May 7, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of equity compensation, which is generally viewed neutrally to positively as it aligns management interests with shareholders. There are no indications of unusual or concerning activity.

Positives

  • The grant of stock options aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages continued service and contribution to the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard equity compensation practices.

Comparison to Industry Standards

  • Stock option grants are a common form of executive compensation in publicly traded companies.
  • The vesting schedule and exercise price are typical for such grants.
  • Companies like Gallup, Press Ganey, and Westat also utilize equity compensation to incentivize their leadership teams.

Stakeholder Impact

  • Shareholders may view the stock option grant as a positive incentive for the director.
  • Employees may see this as a standard practice for executive compensation.

Key Dates

DateDescription
05/07/2025Date of transaction: Parul Bhandari received stock options.
05/09/2025Date of Form 4 filing.
05/07/2035Expiration date of the stock options.

Keywords

stock options, Form 4, National Research Corp, Parul Bhandari, director, beneficial ownership, NRC, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.